A multidimensional landscape of extracellular vesicle-mediated tumor drug resistance: mechanisms, biomarkers, engineered drug delivery, and clinical translation. [PDF]
Fu Z +8 more
europepmc +1 more source
Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation. [PDF]
Barok M +5 more
europepmc +1 more source
Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. [PDF]
Wang H +6 more
europepmc +1 more source
History of trastuzumab: a case study in health technology reassessment and natural disinvestment in Veneto Region. [PDF]
Becchetti AG +3 more
europepmc +1 more source
Loss of meningeal lymphatic endothelial cells results in formation of a newly forming vascular network with scavenging function. [PDF]
Uphoff K +5 more
europepmc +1 more source
Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma. [PDF]
Shih CH, Lin YH, Luo HL, Sung WW.
europepmc +1 more source
The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies. [PDF]
Hurvitz SA, Kakkar R.
europepmc +1 more source

